July 2, 2019 / 5:44 AM / 3 months ago

BRIEF-Novartis to launch generic Iressa when patent expires in Europe

July 2 (Reuters) - Novartis AG:

* SAYS SANDOZ WILL LAUNCH ONCOLOGY GENERIC GEFITINIB IN 13 EU COUNTRIES AT LOSS OF MARKET EXCLUSIVITY

* GEFITINIB IS THE GENERIC NAME FOR IRESSA

* IRESSA SEEN LOSING PATENT PROTECTION IN EUROPE THIS YEAR Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below